1-(3,4-Dimethoxy-phenyl)-3-dimethylamino-propenone, 250mg

Monobutyl Phthalate Copper(II) Salt>95.0%(T)25g

3-(4-(Trifluoromethyl)benzyl)azetidine, 98%, 500mg

Cyclohept-2-enone, 90.0%, 10g

Dicyclohexyl(3-isopropoxy-2',4',6'-triisopropyl-[1,1'-biphenyl]-2-yl)phosphine, 98%, 100mg

N,N,N-Trimethyl-1-(pyridin-2-yl)methanaminium iodide, 95%, 5g

Benzo[e][1,2,3]oxathiazine 2,2-dioxide, 98%, 1g

3-Mesitylpropan-1-ol, 95%, 250mg

(S)-(-)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetic Acid [Optical Resolving]>98.0%(GC)(T)5g

6-METHYL-5-NITRONICOTINIC ACID, 95.0%, 10g

8-ethyl-4-(4-methyl-3-nitrobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

1-[(4-Methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 98%, 250mg

1,4-Dioxane, min. 99.5%, for synthesis, stabilized, 2.5 l, glass packaging